Chronic Lymphocytic Leukemia, CLL Cancer News Articles

Chronic Lymphocytic Leukemia News

CHRONIC LYMPHOCYTIC LEUKEMIA ADVISOR

Chronic Lymphocytic Leukemia News

The majority of patients studied who stopped TKI therapy remained treatment-free at 3 years.

CAR-T and Ibrutinib: Better Together?

Although CAR-T alone has shown utility in CLL, evidence suggests the addition of ibrutinib could improve the durability of remission.
Next post in Chronic Lymphocytic Leukemia